Laboratory Findings in Patients with Probable Dengue Diagnosis from an Endemic Area in Colombia in 2018
- PMID: 34372606
- PMCID: PMC8310201
- DOI: 10.3390/v13071401
Laboratory Findings in Patients with Probable Dengue Diagnosis from an Endemic Area in Colombia in 2018
Abstract
As demonstrated with the novel coronavirus pandemic, rapid and accurate diagnosis is key to determine the clinical characteristic of a disease and to improve vaccine development. Once the infected person is identified, hematological findings may be used to predict disease outcome and offer the correct treatment. Rapid and accurate diagnosis and clinical parameters are pivotal to track infections during clinical trials and set protection status. This is also applicable for re-emerging diseases like dengue fever, which causes outbreaks in Asia and Latin America every 4 to 5 years. Some areas in the US are also endemic for the transmission of dengue virus (DENV), the causal agent of dengue fever. However, significant number of DENV infections in rural areas are diagnosed solely by clinical and hematological findings because of the lack of availability of ELISA or PCR-based tests or the infrastructure to implement them in the near future. Rapid diagnostic tests (RDT) are a less sensitive, yet they represent a timely way of detecting DENV infections. The purpose of this study was to determine whether there is an association between hematological findings and the probability for an NS1-based DENV RDT to detect the DENV NS1 antigen. We also aimed to describe the hematological parameters that are associated with the diagnosis through each test.
Keywords: PCR; dengue virus; hemogram; rapid diagnosis.
Conflict of interest statement
The authors declare no conflict of interest. Disclaimer: The views expressed in this article reflect the results of research conducted by the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. Copyright: Several authors of this paper are employees of the U.S. Government. This work was prepared as part of their official duties. Title 17 U.S.C. §105 provides that ‘Copyright protection under this title is not available for any work of the United States Government.’ Title 17 U.S.C. §101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties.
Figures


Similar articles
-
Utility of dengue NS1 antigen rapid diagnostic test for use in difficult to reach areas and its comparison with dengue NS1 ELISA and qRT-PCR.J Med Virol. 2017 Jul;89(7):1146-1150. doi: 10.1002/jmv.24764. Epub 2017 Feb 27. J Med Virol. 2017. PMID: 28042883
-
Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India.Indian J Med Res. 2020 Jan;151(1):71-78. doi: 10.4103/ijmr.IJMR_613_18. Indian J Med Res. 2020. PMID: 32134017 Free PMC article.
-
Assessment of diagnostic and analytic performance of the SD Bioline Dengue Duo test for dengue virus (DENV) infections in an endemic area (Savannakhet province, Lao People's Democratic Republic).PLoS One. 2020 Mar 17;15(3):e0230337. doi: 10.1371/journal.pone.0230337. eCollection 2020. PLoS One. 2020. PMID: 32182271 Free PMC article.
-
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia.Rev Med Virol. 2021 Mar;31(2):e2161. doi: 10.1002/rmv.2161. Epub 2020 Sep 18. Rev Med Virol. 2021. PMID: 32946149 Free PMC article. Review.
-
Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review.BMC Infect Dis. 2021 Aug 2;21(1):729. doi: 10.1186/s12879-021-06409-9. BMC Infect Dis. 2021. PMID: 34340682 Free PMC article.
Cited by
-
Clinical and Laboratory Features and Treatment Outcomes of Dengue Fever in Pediatric Cases.Cureus. 2024 Dec 16;16(12):e75840. doi: 10.7759/cureus.75840. eCollection 2024 Dec. Cureus. 2024. PMID: 39698191 Free PMC article.
-
Mosquito Salivary Antigens and Their Relationship to Dengue and P. vivax Malaria.Pathogens. 2024 Jan 5;13(1):52. doi: 10.3390/pathogens13010052. Pathogens. 2024. PMID: 38251359 Free PMC article.
References
-
- WHO . Dengue and Severe Dengue Fact Sheet. WHO; Geneva, Switzerland: 2020.
-
- Tsai J.J., Chan K.S., Chang J.-S., Chang K., Lin C.C., Huang J.H., Lin W.R., Chen T.C., Hsieh H.C., Lin S.H., et al. Effect of serotypes on clinical manifestations of dengue fever in adults. J. Microbiol. Immunol. Infect. 2009;42:471–478. - PubMed
-
- Suppiah J., Ching S.M., Amin-Nordin S.A., Mat-Nor L.-A., Ahmad-Najimudin N.-A., Low G.K.K., Abdul-Wahid M.-Z., Thayan R., Chee H.-Y. Clinical manifestations of dengue in relation to dengue serotype and genotype in Malaysia: A retrospective observational study. PLOS Negl. Trop. Dis. 2018;12:e0006817. doi: 10.1371/journal.pntd.0006817. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials